---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-078612"
form_type: "8-K"
ticker: "AWHL"
cik: "0000926617"
company_name: "Aspira Women's Health Inc."
filed_at: "2024-06-27T23:59:59+00:00"
generated_at: "2026-06-01T01:18:13.041972+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Aspira Women's Health CFO Torsten Hombeck terminated for cause; CEO interim CFO

## Summary
- Dr. Torsten Hombeck terminated as CFO on June 27, 2024 due to personal civil matter unrelated to Company.
- Termination deemed 'for cause' under employment agreement; no further payments beyond June 28, 2024 salary.
- CEO Nicole Sandford assumes CFO duties on interim basis; search for permanent replacement underway.
- Separate June 5, 2024 amendment had raised Hombeck's base salary to $375,000 and added Corporate Secretary title.

## SEC filing metadata
- accession: 0000950170-24-078612
- form_type: 8-K
- ticker: AWHL
- cik: 0000926617
- company_name: Aspira Women's Health Inc.
- filed_at: 2024-06-27T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926617/000095017024078612/0000950170-24-078612-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926617/000095017024078612/awh-20240627.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-078612
- JSON: https://secwatch.observer/filing/0000950170-24-078612.json
- Plain text: https://secwatch.observer/filing/0000950170-24-078612.txt

## Key facts
- Executive change
  Nicole Sandford was appointed as Chief Financial Officer (interim) at Aspira Women's Health Inc..
  - Action: appointed interim CFO
  - Role: Chief Financial Officer (interim)
  source text: As of June 27, 2024, Nicole Sandford, the Company’s Chief Executive Officer, has taken over Dr. Hombeck’ s duties on an interim basis until a search for his replacement is completed.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000095017024078612/0000950170-24-078612-index.htm
- Executive change
  Torsten Hombeck departed as Chief Financial Officer at Aspira Women's Health Inc..
  - Action: terminated for cause
  - Role: Chief Financial Officer
  source text: On June 27, 2024, the Compensation Committee (the “Committee”) of Aspira Women’s Health Inc. (the “Company”) determined that a personal civil matter interfered with Dr. Torsten Hombeck’ s ability to continue to serve as the Company’s Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000095017024078612/0000950170-24-078612-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.